Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine + Sovodak versus chloroquine + Kaletra for hospitalized adults with COVID-19
IRCT20200328046885N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing chloroquine + Sovodak with chloroquine + Kaletra (2 arms). Primary endpoints: Mortality rate, Duration of hospitalization and 1 more. Started Jul 2020; status: completed.
02
Drugs
chloroquinesofosbuvir + daclatasvirlopinavir + ritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200328046885N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200328046885N1.